Sanara MedTech Inc.
SMTI
$33.95
$3.4311.24%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 42.89% | -129.25% | 46.16% | 18.44% | -98.62% |
Total Depreciation and Amortization | -0.91% | 2.07% | -0.21% | -0.14% | 0.01% |
Total Amortization of Deferred Charges | 23.95% | 0.00% | 20.28% | -49.59% | 3,054.84% |
Total Other Non-Cash Items | 3.91% | 180.97% | -49.87% | -3.51% | 95.90% |
Change in Net Operating Assets | 127.85% | -797.18% | -81.29% | 263.59% | 43.19% |
Cash from Operations | 233.27% | -314.47% | -54.55% | 245.23% | 11.45% |
Capital Expenditure | -2.25% | -2,285.87% | -693.41% | 84.52% | 10.64% |
Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 98.73% | -5,985.12% | 99.09% | -- | -- |
Cash from Investing | 24.17% | -3,884.54% | 97.96% | -10,711.39% | 10.64% |
Total Debt Issued | -100.37% | -- | -100.00% | 7.89% | -- |
Total Debt Repaid | -- | -- | -- | 100.00% | -- |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -3,003.46% | 93.50% | -51.42% | -284.40% | 165.29% |
Cash from Financing | -120.56% | 1,098.28% | -108.32% | 201.15% | 827.50% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -177.54% | 1,305.69% | -103.94% | 204.83% | 243.26% |